68Ga-DOTATOC PET/CT after 1 cycle of PRRT with 90Y-DOTATOC visualizes changes in somatostatin receptor availability in neuroendocrine tumours

被引：0
|
作者：
Van Binnebeek, S. [1 ]
Mottaghy, F. M. [2 ]
Koole, M. [1 ]
Baete, K. [1 ]
Vanbilloen, B. [1 ]
Terwinghe, C. [1 ]
Clement, P. [1 ]
Verbruggen, A. [1 ]
Mortelmans, L. [1 ]
Van Cutsem, E. [1 ]
Haustermans, K. [1 ]
Verslype, C. [1 ]
Deroose, C. M. [1 ]
机构：
[1] UZ Leuven, Louvain, Belgium
[2] UK Aachen, Aachen, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2010年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S367 / S367
页数：1
相关论文
共 50 条
  • [1] 68Ga-DOTATOC PET/CT in the monitoring of 90Y-DOTATOC treatment
    Versari, Annibale
    Fraternali, Alessandro
    Frasoldati, Andrea
    Carpi, Amalia
    Asti, Mattia
    Filice, Angelina
    Di Paolo, Maria Liberata
    Fioroni, Federica
    Giunta, Francesca
    Calandri, Enrico
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [2] Evaluation of the pharmacokinetics of 68Ga-DOTATOC in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy
    Koukouraki, S
    Strauss, LG
    Georgoulias, V
    Schuhmacher, J
    Haberkorn, U
    Karkavitsas, N
    Dimitrakopoulou-Strauss, A
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (04) : 460 - 466
  • [3] Evaluation of the pharmacokinetics of 68Ga-DOTATOC in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy
    Sophia Koukouraki
    Ludwig G. Strauss
    Vassilios Georgoulias
    Jochen Schuhmacher
    Uwe Haberkorn
    Nikolaos Karkavitsas
    Antonia Dimitrakopoulou-Strauss
    European Journal of Nuclear Medicine and Molecular Imaging, 2006, 33 : 460 - 466
  • [4] Evaluation of 68Ga-DOTATOC PET/MRI for whole-body staging of neuroendocrine tumours in comparison with 68Ga-DOTATOC PET/CT
    Lino M. Sawicki
    Cornelius Deuschl
    Karsten Beiderwellen
    Verena Ruhlmann
    Thorsten D. Poeppel
    Philipp Heusch
    Harald Lahner
    Dagmar Führer
    Andreas Bockisch
    Ken Herrmann
    Michael Forsting
    Gerald Antoch
    Lale Umutlu
    European Radiology, 2017, 27 : 4091 - 4099
  • [5] Evaluation of 68Ga-DOTATOC PET/MRI for whole-body staging of neuroendocrine tumours in comparison with 68Ga-DOTATOC PET/CT
    Sawicki, Lino M.
    Deuschl, Cornelius
    Beiderwellen, Karsten
    Ruhlmann, Verena
    Poeppel, Thorsten D.
    Heusch, Philipp
    Lahner, Harald
    Fuehrer, Dagmar
    Bockisch, Andreas
    Herrmann, Ken
    Forsting, Michael
    Antoch, Gerald
    Umutlu, Lale
    EUROPEAN RADIOLOGY, 2017, 27 (10) : 4091 - 4099
  • [6] Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy
    Sophia Koukouraki
    Ludwig G. Strauss
    Vassilios Georgoulias
    Michael Eisenhut
    Uwe Haberkorn
    Antonia Dimitrakopoulou-Strauss
    European Journal of Nuclear Medicine and Molecular Imaging, 2006, 33 : 1115 - 1122
  • [7] Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy
    Koukouraki, Sophia
    Strauss, Ludwig G.
    Georgoulias, Vassilios
    Eisenhut, Michael
    Haberkorn, Uwe
    Dimitrakopoulou-Strauss, Antonia
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (10) : 1115 - 1122
  • [8] SUV of 68Ga-DOTATOC PET/CT predicts response probability of PRRT in neuroendocrine tumors
    Stefanova, Melsa
    Kratochwil, Clemens
    Mavriopoulou, Elena
    Afshar-Oromieh, Ali
    Mier, Walter
    Schwartz, Lawrence
    Haberkorn, Uwe
    Giesel, Frederik
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [9] Peptide receptor radionuclide therapy of neuroendocrine tumors with 90Y-DOTATOC: Is treatment response predictable by pre-therapeutic uptake of 68Ga-DOTATOC?
    Oeksuez, M. Oe.
    Winter, L.
    Pfannenberg, C.
    Reischl, G.
    Muessig, K.
    Bares, R.
    Dittmann, H.
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2014, 95 (03) : 289 - 300
  • [10] Intraarterial Treatment of GEP NET: 68Ga-DOTATOC SUV Cannot Predict 90Y-DOTATOC Uptake
    Brogsitter, Claudia
    Faulhaber, Diana
    Kotzerke, Joerg
    CLINICAL CANCER RESEARCH, 2011, 17 (07) : 2065 - 2065
12345